首页|不同剂量人免疫球蛋白联合阿司匹林治疗小儿川崎病的效果及对血管内皮功能、氧化应激指标的影响

不同剂量人免疫球蛋白联合阿司匹林治疗小儿川崎病的效果及对血管内皮功能、氧化应激指标的影响

Effect of different doses of human immunoglobulin combined with aspirin in the treatment of Kawasaki disease in children and its influences on vascular endothelial function and oxidative stress indexes

扫码查看
目的 探讨不同剂量人免疫球蛋白联合阿司匹林治疗小儿川崎病的效果.方法 选取 2020 年 4月至2022年4月我科收治的 60 例川崎病患儿,以随机数字表法将其分为对照组和观察组,每组 30 例.对照组采用 1.0 g/(kg·d)人免疫球蛋白联合阿司匹林治疗,观察组采用 2.0 g/(kg·d)人免疫球蛋白联合阿司匹林治疗.比较两组的治疗效果.结果 观察组的治疗总有效率高于对照组,差异具有统计学意义(P<0.05).治疗后,两组的抗内皮细胞抗体(AECA)、抗中性粒细胞胞质抗体(ANCA)及血管内皮生长因子(VEGF)水平均降低,且观察组低于对照组,差异具有统计学意义(P<0.05).治疗后,两组的超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)水平均升高,丙二醛(MDA)水平均降低,且观察组优于对照组,差异具有统计学意义(P<0.05).治疗后,两组的可溶性白细胞介素-2 受体(sIL-2R)、脂蛋白相关磷脂酶A2(Lp-PLA2)水平均降低,且观察组低于对照组,差异具有统计学意义(P<0.05).两组的不良反应总发生率无明显差异(P>0.05).结论 采用 2.0 g/(kg·d)人免疫球蛋白联合阿司匹林治疗小儿川崎病的效果优于 1.0 g/(kg·d)人免疫球蛋白,在改善血管内皮功能、氧化应激反应及免疫炎症方面更具优势,且安全性高.
Objective To explore the effect of different doses of human immunoglobulin combined with aspirin in the treatment of Kawasaki disease in children.Methods Sixty children with Kawasaki disease admitted in our department from April 2020 to April 2022 were selected and divided into control group and observation group by random number table method,with 30 cases in each group.The control group was treated with 1.0 g/(kg·d)human immunoglobulin combined with aspirin,and the observation group was treated with 2.0 g/(kg·d)human immunoglobulin combined with aspirin.The therapeutic effects of the two groups were compared.Results The total effective rate of treatment in the observation group was higher than that in the control group,and the difference was statistically significant(P<0.05).After treatment,the levels of anti-endothelial cell antibodies(AECA),anti-neutrophil cytoplasmic antibodies(ANCA)and vascular endothelial growth factor(VEGF)in the two groups decreased,and those in the observation group were lower than the control group,and the differences were statistically significant(P<0.05).After treatment,the levels of superoxide dismutase(SOD)and glutathione peroxidase(GSH-Px)in the two groups increased,and the levels of malondialdehyde(MDA)decreased,and those in the observation group were better than the control group,and the differences were statistically significant(P<0.05).After treatment,the levels of soluble interleukin-2 receptor(sIL-2R)and lipoprotein-associated phospholipase A2(Lp-PLA2)in the two groups decreased,and those in the observation group were lower than the control group,and the differences were statistically significant(P<0.05).There was no significant difference in the total incidence of adverse reactions between the two groups(P>0.05).Conclusion The 2.0 g/(kg·d)human immunoglobulin combined with aspirin in the treatment of Kawasaki disease in children has better effect than that of 1.0 g/(kg·d)human immunoglobulin,which has more advantages in improving vascular endothelial function,oxidative stress response and immune inflammation,and has high safety.

human immunoglobulinaspirinKawasaki diseasevascular endothelial functionoxidative stress

成晓燕、任永勤

展开 >

渭南市第一医院儿科,陕西 渭南,714000

人免疫球蛋白 阿司匹林 川崎病 血管内皮功能 氧化应激

2024

临床医学研究与实践

临床医学研究与实践

ISSN:
年,卷(期):2024.9(16)
  • 1